The First Affiliated Hospital Of Zhengzhou University

This study is comparing a new two-drug combination (anlotinib + benmelstobart) against the current standard treatment (toripalimab + chemotherapy) for people with advanced esophageal cancer that has specific gene changes. It aims to see if the new combination is safer and more ef…

This study is testing a new drug combination for people with advanced stomach cancer that has gotten worse after their first treatment. It will check the safety of the drugs and see if they help shrink tumors. The treatment involves an experimental immune-boosting drug (IBI363) g…

This study is testing a new two-drug combination for women whose ovarian cancer has returned and stopped responding to standard platinum-based chemotherapy. It will enroll about 30 participants to see if combining an antibody-drug conjugate (sacituzumab tirumotecan) with an exist…

This study is testing a new rinse solution used during colonoscopy to see if it helps doctors find more polyps. The solution contains menthol to relax the colon and simethicone to clear away bubbles, aiming to give doctors a clearer view. About 500 adults scheduled for colonoscop…

This study is testing if a combination of two therapies can help stroke survivors regain movement in their paralyzed limbs. The therapies are blood flow restriction training (light exercise with a cuff) and repetitive transcranial magnetic stimulation (a non-invasive brain stimul…

This study is testing whether spraying a menthol solution into the colon during a colonoscopy can relax muscle spasms. Researchers want to see if reducing spasms makes the procedure more comfortable and helps doctors spot more precancerous growths (adenomas). They will enroll 440…